Strategies adopted in a southern Italian referral centre to reduce adalimumab discontinuation: comment on ‘Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?’
Fabrizio Martora, Claudio Marasca, Gabriella Fabbrocini, Angelo Ruggiero
Topics & Concepts
Hidradenitis suppurativaAdalimumabMedicineDiscontinuationReferralDermatologyDrugTertiary referral centreSurgeryInternal medicineFamily medicinePharmacologyTumor necrosis factor alphaDiseaseHidradenitis Suppurativa and TreatmentsMicroscopic ColitisColorectal and Anal Carcinomas